Cardiopulmonary bypass may alter the factors responsible for normal hemostasis by exposing blood to nonendothelial surfaces, for example, extracorporeal circuits. To evaluate the probable effect of extracorporeal circulation on hemostasis, we measured thrombin-antithrombin III complex (TAT) and prothrombin fragment 1+2 (PF 1.2) plasma levels, which are the biologic markers of in vivo coagulation, in 20 patients who underwent coronary artery bypass grafting (CABG). Postoperative PF 1.2 levels were higher in comparison to the preoperative concentrations of the parameter. Preoper-and postoperative TAT concentrations showed no statistically significant difference. The increment in the PF 1.2 levels in CABG patients might suggest ongoing subclinical hemostatic activation associated with CABG. Further investigations are needed to clarify the exact relationship between increased PF 1.2 levels and thrombotic complications observed in CABG patients. Hemostatis in CABG is still an enigma and remains to be eluciated.
Cardiopulmonary bypass replaces the functions of the heart and the lung in open heart surgery and the circuitry consists of a pump, a disposable oxygenator, reservoirs, and tubing systems. The normal functions of blood flow, gas exchange, blood surface interface effects, and reticuloendothelial function are replaced totally or in part by the extracorporeal bypass. Nonphysiologic parameters of the extracorporeal circulation (ECC) are the nonpulsatile flow, anticoagulation, hemodilution, hypothermia, and relative hypoperfusion. During ECC the blood is exposed to large foreign surfaces and materials and flow conditions normally not found in the circulation (1) . All of these factors affect the platelet funciton, the coagulation, and fibrinolytic system.
Normally, there is a continuous fibrin formation on the endothelial surface that is balanced with concomitant fibrinolysis. If this is disturbed, clotting mechanisms take place. Fibrinogen adheres to the circuit surfaces, which later on binds platelet and clotting mechanism is activated and plasminogen activation and fibrinolysis occur (1, 2) . Heparinization is used to prevent the blood coagulation during ECC. Initially the levels of factors V, VII, antithrombin III, plasminogen, alpha-2 antiplasmin decrease during ECC that is due to hemodilution, subsequently increase due to synthesis by the liver. Platelet concentrations drop during the ECC. Platelet functions alter (insensitive to ADP and epinephrine) and activation occurs (1, 3) . Depending upon previously mentioned interrelationships between hemostasis and open heart surgery. To assess whether there is a subclinical activation of the hemostatic system associated with open heart surgery, in vivo molecular markers of hemostatic activation (namely prothrombin fragments 1 + 2 and thrombin-antithrombin III complex) were determined preoperatively and at the end of the cardiopulmonary bypass in operated patients (4) .
MATERIALS AND METHODS
The study was carried out on sixteen patients (15 men and 5 women) who underwent CABG in Hacettepe University Thoracic and Cardiovascular Surgery Department. Patients were between 38 and 67 years of age. Patients with impaired renal function, with bleeding diathesis, who were receiving antiaggregant or anticoagulant therapy (salisylic acid, heparin, warfarin, nonsteroidal antiinflammatory drugs) and fibrinolytic medication and patients with cadiopulmonary bypass times less than 60 minutes were not included into the study group. In all patients Univox membrane oxygenator (Bentley, Irvine CA), De Bakey roller pump and Bentley Duraflo II pump systems were used. The patients were cooled to 280C and cold potassium cardioplegia was applied. The perfusion pressure was kept above 40 mmHg. Bypass flow rates were maintained at 2.4 L/m2/min. Heparin 3 mg/kg (Liquemine, Roche) was administered before cannulation and activated clotting time (ACT) was kept above 400 seconds (Hemochrone, International Technidyne Corp. Edison, NJ) and neutralization of the heparin after the bypass was achieved by protamine hydrochloride (Protamin, Roche) administration. Blood specimens were obtained from the patients before the bypass procedure and 24 hours after the operation and plasma prothrombin fragment 1 + 2 (PF 1.2) and thrombin-antithrombin III complex (TAT) levels were determined. PF 1.2 and TAT concentrations in plasma samples were measured by solid phase sandwich ELISA method (Enzygnost F 1+2 and Enzygnost TAT microenzyme immunoassay, Behringwerke AG, Germany).
Results were expressed as mean + standard deviation (SD). Statistical significance was assigned to p concentrations lower than 0.05. For comparison of the pre-and postoperative PF 1.2 and TAT concentrations, Wilcoxon test was used. SPSS (Statistical Package for Social Sciences) for Windows 5.0 was used to analyze the data.
RESULTS
The preoperative and postoperative concentrations of TAT and PF 1.2 in plasma were compared. Postoperative plasma concentrations of PF 1.2 were higher in comparison to preoperative concentrations of the parameter. Pre-and postoperative TAT concentrations showed no significant difference. Results are shown in Table 1 .
DISCUSSION
The exposure of blood to foreign surfaces during cardiopulmonary bypass leads to activation of coagulation and fibrinolytic systems. Despite a normal clotting mechanism before the operation many patients suffer from postoperative bleeding while laboratory measurements of hemostasis show only mild abnormalities and no specific deficiencies. PF 1.2, the peptide fragment generated when prothrombin is activated to thrombin, reflects thrombin generation and is found during the activation of coagulation and indicates some fibrin have already been formed. Thrombin formation is proceeded by formation of complexes with serine protease inhibitor, antithrombin III yielding TAT. These two markers of coagulation circulate in the blood of patients who suffer from any kind of thrombotic disorders. In vivo molecular hemostatic markers show hemostatic system activation. In our study, the increment in the PF 1.2 levels in CABG patients was statistically significant. This finding might suggest ongoing sub- clinical hemostatic activation associated with extracorporeal circulation. On the other hand, the increment in TAT concentrations after 24 hours of CABG was not statistically significant. Our results are in concordance with the results of other studies (5) (6) (7) . Some studies report that the changes in the levels of these hemostatic markers continue for up to fifth postoperative day (6) . Further investigations are required to clarify the exact relationship between increased PF 1.2 levels and thrombotic complications observed in patients who underwent CABG. Hemostasis in open heart surgery is still an enigma and remains to be elucidated. The data suggest that open heart surgery induced hypercoagulability due to excessive thrombin generation.
